您当前的位置：
首页 >
文章列表页 >
Cost-effectiveness analysis of onradivir and oseltamivir for the treatment of influenza A in adults
更新时间：2026-06-26

    • Cost-effectiveness analysis of onradivir and oseltamivir for the treatment of influenza A in adults

    • ZHONGGUO YAOFANG   Vol. 37, Issue 12, Pages: 1579-1583(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.12.10    

      CLC： R956

    • Received：15 January 2026，

      Revised：2026-06-11，

      Accepted：12 June 2026，

      Published：30 June 2026

    移动端阅览

  • ZHANG Yongzan,GAO Shengnan,WANG Xianying,et al.Cost-effectiveness analysis of onradivir and oseltamivir for the treatment of influenza A in adults[J].ZHONGGUO YAOFANG,2026,37(12):1579-1583. DOI： 10.6039/j.issn.1001-0408.2026.12.10.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

泮托拉唑与雷尼替丁治疗胃食管反流的药物经济学评价
喜炎平注射液和利巴韦林注射液治疗普通型儿童手足口病的成本-效果分析
卡泊芬净与伏立康唑在中性粒细胞缺乏伴发热患者中初始经验性抗真菌治疗的经济学评价
脉络宁注射液与复方丹参注射液治疗缺血性脑卒中的成本-效果分析
帕拉米韦对比奥司他韦治疗流行性感冒合并热性惊厥患儿的药

Related Author

ZHANG Jiaxing
XIE Juan
GAO Ling
LI Lianhua
WANG Zhongyuan
WANG Ting
XIONG Fen
TANG Hongmei

Related Institution

School of International Pharmaceutical Business， China Pharmaceutical University
School of Pharmacy，Hebei Medical University
Dept. of Medical Insurance，the Second Hospital of Hebei Medical University
Dept. of Pharmacy，the Second Hospital of Hebei Medical University
0